[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
April 1999

Extracorporeal Photochemotherapy for the Treatment of Erythrodermic Pityriasis Rubra Pilaris

Author Affiliations

Not Available

Arch Dermatol. 1999;135(4):475-476. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-4-dlt0499

Pityriasis rubra pilaris (PRP) is a rare papulosquamous disorder of unknown origin. Although PRP usually resolves within 1 to 3 years,1 treatment of the disease is generally difficult. Encouraged by good results with extracorporeal photochemotherapy (ECP) in patients with erythroderma of other origin,24 we treated 2 patients with erythrodermic PRP type I using ECP in combination with systemic retinoids and cyclosporine, respectively.

First Page Preview View Large
First page PDF preview
First page PDF preview
×